
News
from the fight to #SaveIndiePharmacy
New York Times’ The Middlemen series

Ex-FTC lawyers form new firm targeting US antitrust enforcement ‘gaps’
Three former U.S. Federal Trade Commission lawyers and a U.S. attorney who resigned in January opened a new plaintiffs law firm on Tuesday focused on unfair competition, price discrimination and other antitrust law violations.

PBM Legislation in the Reconciliation Bill is Far From Sweeping PBM Reform
Over the past few years, Congress has attempted to pass “federal PBM reform.” Members of Congress have held numerous hearings related to PBMs and introduced numerous bills seeking to regulate PBMs. Despite the rhetoric in Washington about bipartisan support to regulate PBMs, Congress has not been able to pass meaningful PBM reform.
Drugmakers including Purdue Pharma paid pharmacy benefit managers not to restrict painkiller prescriptions, a New York Times investigation found.